Beijing Sunshine Novo Pharmaceutical Research

Beijing Sunshine Novo Pharmaceutical Research is a leading Chinese Contract Research Organization (CRO) providing integrated R&D services across the entire drug development lifecycle. Founded in 2009 and headquartered in Beijing, the company specializes in drug discovery, CMC (Chemistry, Manufacturing, and Controls), clinical trials, and bioequivalence studies. Sunshine Novo focuses on high-end generic drugs, innovative drugs, and complex formulations, including peptides and inhalation products. The company is listed on the Shanghai Stock Exchange STAR Market and serves a broad client base of pharmaceutical companies globally, offering a 'one-stop' service model from laboratory research to regulatory approval.